Chang TW, Weinstein L, MacMahon HE. Paralytic poliomyelitis in a child with hypogamma-globulinemia: probable implication of type I vaccine strain. Pediatrics 1966;37:630-636.

Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, et al. The Vaccine Adverse Event Reporting System (VAERS). Atlanta: Centers for Disease Control; submitted for publication.

Christensen PE. Side reactions to tetanus toxoid. Scientific Publication, Pan American Health Organization 1972;253:36-43.

Coffin CM, Roberts RL, Monafo WJ, Haslam DB, Bellini W J, Zaki S, et al. Disseminated measles infection following vaccination in severe combined immune deficiency syndrome. Society for Pediatric Pathology 1993; 13:102.


Davis LE, Bodian D, Price D, Butler IJ, Vickers JH. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. New England Journal of Medicine 1977;297:241-245.


Ehrengut W, Ehrengut-Lange J. Interkurrente todliche Erkrankungen nach Polioschluckimpfung und Pockenschutzimpfung. [Intercurrent fatal diseases after oral polio vaccination and smallpox vaccination.] Munchener Medizinische Wochenschrift 1969;111:1092-1099.


Gaebler JW, Kleiman MB, French ML, Chastain G, Barrett C, Griffin C. Neurologic complications in oral polio vaccine recipients. Journal of Pediatrics 1986;108:878-881.

Garenne M, Leroy O, Beau J-P, Sene I. Child mortality after high titre measles vaccines: prospective study in Senegal. Lancet 1991;338:903-907.

Gross TP, Khurana RK, Higgins T, Nkowane BS, Hirsch RL. Vaccine-associated poliomyelitis in a household contact with Netherton's syndrome receiving long-term steroid therapy. American Journal of Medicine 1987;83:797-800.


Haun U, Ehrhardt G. Zur problematik postvakzinaler Komplikationen nach Masernschutzimpfung. [Postvaccinal complications following protective vaccination against measles.] Deutsche Gesundheitswesen 1973;28:1306-1308.

Hirayama M. Measles vaccines used in Japan. Reviews of Infectious Diseases 1983;5:495-503.

Hoffman HJ, Hunter JC, Damus K, Pakter J, Peterson DR, van Belle G, Hasselmeyer EG. Diphtheria-tetanus-pertussis immunization and sudden infant death: results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome Risk Factors. Pediatrics 1987;79:598-611.

Hong R, Gilbert EF, Opitz JM. Omenn disease: termination in lymphoma. Pediatric Pathology 1985;3:143-154.


Institute of Medicine. Adverse Effects of Pertussis and Rubella Vaccines. Washington, DC: National Academy Press; 1991.


Korger G, Quast U, Dechert G. Tetanusimpfung: Vertraglichkeit und Vermeidung von Nebenreaktionen. [Tetanus vaccination: tolerance and avoidance of adverse reactions.] Klminische Wochenschrift 1986:64:767-775.

Kovalskaya SI. Anafilaktogennye svoistva adsorbipovannoi i neadsorbirovannoi kokliusnodifterino-stolbniachnoi vaktsin. [The anaphylactogenic properties of absorbed and nonabsorbed pertussis-diphtheria-tetanus vaccines.] Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii 1967;44:105-109.


Landrigan PJ, Witte JJ. Neurologic disorders following live measles-virus vaccination. Journal of the American Medical Association 1973;223:1459-1462.

Little RE, Peterson DR. Sudden infant death syndrome epidemiology: a review and update. Epidemiologic Reviews 1990:12:241-246.


Mawhinney H, Allen IV, Beare JM, Bridges JM, Connolly HH, Haire M, et al. Dysgamma-globulinaemia complicated by disseminated measles. British Medical Journal 1971;2:380-381.

Miller CL. Surveillance after measles vaccination in children. The Practitioner 1982;226:535-537.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement